347 related articles for article (PubMed ID: 18799045)
1. [Research advances in Xp11.2 translocation renal cell carcinoma].
Huang JH; Zhou FJ
Ai Zheng; 2008 Sep; 27(9):1006-8. PubMed ID: 18799045
[TBL] [Abstract][Full Text] [Related]
2. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.
Argani P; Olgac S; Tickoo SK; Goldfischer M; Moch H; Chan DY; Eble JN; Bonsib SM; Jimeno M; Lloreta J; Billis A; Hicks J; De Marzo AM; Reuter VE; Ladanyi M
Am J Surg Pathol; 2007 Aug; 31(8):1149-60. PubMed ID: 17667536
[TBL] [Abstract][Full Text] [Related]
3. Renal cell carcinoma associated with transcription factor E3 expression and Xp11.2 translocation: incidence, characteristics, and prognosis.
Klatte T; Streubel B; Wrba F; Remzi M; Krammer B; de Martino M; Waldert M; Marberger M; Susani M; Haitel A
Am J Clin Pathol; 2012 May; 137(5):761-8. PubMed ID: 22523215
[TBL] [Abstract][Full Text] [Related]
4. Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations.
Altinok G; Kattar MM; Mohamed A; Poulik J; Grignon D; Rabah R
Pediatr Dev Pathol; 2005; 8(2):168-80. PubMed ID: 15747097
[TBL] [Abstract][Full Text] [Related]
5. Xp11 translocation carcinoma of the kidney presenting with multilocular cystic renal cell carcinoma-like features.
Suzigan S; Drut R; Faria P; Argani P; De Marzo AM; Barbosa RN; Mello Denadai ER; Martins-Filho J; Martucci RC; Bauab T
Int J Surg Pathol; 2007 Apr; 15(2):199-203. PubMed ID: 17478783
[TBL] [Abstract][Full Text] [Related]
6. Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas.
Mosquera JM; Dal Cin P; Mertz KD; Perner S; Davis IJ; Fisher DE; Rubin MA; Hirsch MS
Diagn Mol Pathol; 2011 Sep; 20(3):129-37. PubMed ID: 21817901
[TBL] [Abstract][Full Text] [Related]
7. Pediatric renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion.
Winarti NW; Argani P; De Marzo AM; Hicks J; Mulyadi K
Int J Surg Pathol; 2008 Jan; 16(1):66-72. PubMed ID: 18203790
[TBL] [Abstract][Full Text] [Related]
8. TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.
Rao Q; Williamson SR; Zhang S; Eble JN; Grignon DJ; Wang M; Zhou XJ; Huang W; Tan PH; Maclennan GT; Cheng L
Am J Surg Pathol; 2013 Jun; 37(6):804-15. PubMed ID: 23598965
[TBL] [Abstract][Full Text] [Related]
9. Renal cell carcinoma with MiTF/TFE3 translocation in children: report of a case at the stage of lymph node involvement.
Fall B; Sarr A; Sow Y; Diao B
Afr J Paediatr Surg; 2011; 8(3):317-9. PubMed ID: 22248899
[TBL] [Abstract][Full Text] [Related]
10. A novel case of t(X;1)(p11.2;p34) in a renal cell carcinoma with TFE3 rearrangement and favorable outcome in a 57-year-old patient.
Haudebourg J; Hoch B; Fabas T; Burel-Vandenbos F; Carpentier X; Amiel J; Cardot-Leccia N; Michiels JF; Pedeutour F
Cancer Genet Cytogenet; 2010 Jul; 200(2):75-8. PubMed ID: 20620589
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic and molecular genetic study of renal cell carcinoma occurring in teenagers].
Rao Q; Zhou J; Zhang RS; Ma HH; Zhou HB; Lu ZF; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):582-6. PubMed ID: 21092583
[TBL] [Abstract][Full Text] [Related]
12. Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry.
Komai Y; Fujiwara M; Fujii Y; Mukai H; Yonese J; Kawakami S; Yamamoto S; Migita T; Ishikawa Y; Kurata M; Nakamura T; Fukui I
Clin Cancer Res; 2009 Feb; 15(4):1170-6. PubMed ID: 19228722
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of key cell cycle regulators in renal cell carcinoma associated with Xp11.2 translocation.
Barroca H; Castedo S; Vieira J; Teixeira M; Müller-Höcker J
Pathol Res Pract; 2009; 205(7):466-72. PubMed ID: 19246164
[TBL] [Abstract][Full Text] [Related]
14. Biological characteristics of pediatric renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.
Song HC; Sun N; Zhang WP; He L; Fu L; Huang C
J Pediatr Surg; 2014 Apr; 49(4):539-42. PubMed ID: 24726108
[TBL] [Abstract][Full Text] [Related]
15. An aggressive course of Xp11 translocation renal cell carcinoma in a 28-year-old man.
Koie T; Yoneyama T; Hashimoto Y; Kamimura N; Kusumi T; Kijima H; Ohyama C
Int J Urol; 2009 Mar; 16(3):333-5. PubMed ID: 19298350
[TBL] [Abstract][Full Text] [Related]
16. Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.
Green WM; Yonescu R; Morsberger L; Morris K; Netto GJ; Epstein JI; Illei PB; Allaf M; Ladanyi M; Griffin CA; Argani P
Am J Surg Pathol; 2013 Aug; 37(8):1150-63. PubMed ID: 23715164
[TBL] [Abstract][Full Text] [Related]
17. Translocation renal cell carcinoma: lack of negative impact due to lymph node spread.
Geller JI; Argani P; Adeniran A; Hampton E; De Marzo A; Hicks J; Collins MH
Cancer; 2008 Apr; 112(7):1607-16. PubMed ID: 18278810
[TBL] [Abstract][Full Text] [Related]
18. [A case of xp11.2 translocation renal cell carcinoma].
Horie K; Kikuchi M; Miwa K; Minamidate Y; Yokoi S; Nakano M; Deguchi T; Ehara H; Asano N; Hirose Y
Hinyokika Kiyo; 2011 Mar; 57(3):129-33. PubMed ID: 21586884
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features of Xp11.2 translocation renal cell carcinoma.
Lim B; You D; Jeong IG; Kwon T; Hong S; Song C; Cho YM; Hong B; Hong JH; Ahn H; Kim CS
Korean J Urol; 2015 Mar; 56(3):212-7. PubMed ID: 25763125
[TBL] [Abstract][Full Text] [Related]
20. Renal cell carcinoma with Xp11.2 translocation in a 7-year-old boy.
Jayasinghe C; Siegler N; Leuschner I; Fleischhack G; Born M; Müller AM
Klin Padiatr; 2010 May; 222(3):187-9. PubMed ID: 20514625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
